Grant: Engage Grants Program
Institut national de la recherche scientifique
$24,978.00
Design of assays to measure binding between peptidoglycan and novel glycopeptide-like molecules and to describe mechanisms of actions of these novel molecules.
FY 2016-17
Summary
The peptidoglycan (PG) or cell wall (exoskeleton) is an essential constituent of nearly all bacteria. It helpsbacteria to survive turgor pressure and determine the shape of the cell. Glycopeptide molecules are a class ofantibiotic broadly used in human and animal health that targets the synthesis of this macromolecule. ParazaPharma Inc is a research organisation specialized in helping other company in drug discovery. They alsodevelop in-house program of drug discovery and some of them are related to the design of novelglycopeptides-like molecules. Several of these molecules, such as PAR-00387, are toxic for numerous bacteriaincluding Gram-positive animal and human pathogens but the mechanism of action is not known. Theycontacted the lab. of Dr. Veyrier, expert in bacterial cell wall synthesis to answer the specific fundamentalquestions of the mechanism of action of these novel molecules and if they target peptidoglycan. We willtherefore design assays to determine if these molecule can bind and target the synthesis of PG using innovativeand optimized HPLC and electron microscopy protocols. This knowledge will not only help in thecommercialization of this molecule, it will also help in determining the prerequisite for glycopetides to bindPG, and the consequence of inhibiting some steps in PG synthesis on the development of the bacterialcell-cycle.
Program
Engage Grants Program
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
508023-2016
Name nom
Veyrier, Frederic
Department département
INRS-Institut Armand-Frappier
Organization id
56
Institution établissement
Institut national de la recherche scientifique
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2016
Competition year année de concours
2016
Award amount
24978
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1552
Committee name en
Quebec Internal Decision Committee
Committee name fr
Comité de décision interne pour le Québec
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
5200
Research subject group en
Microbiology
Research subject group fr
Microbiologie
Research subject en
Microbiology
Research subject fr
Microbiologie
Partie
1
Nb partie
1
Application title
Design of assays to measure binding between peptidoglycan and novel glycopeptide-like molecules and to describe mechanisms of actions of these novel molecules.
Keyword
NSERC
Application summary
The peptidoglycan (PG) or cell wall (exoskeleton) is an essential constituent of nearly all bacteria. It helpsbacteria to survive turgor pressure and determine the shape of the cell. Glycopeptide molecules are a class ofantibiotic broadly used in human and animal health that targets the synthesis of this macromolecule. ParazaPharma Inc is a research organisation specialized in helping other company in drug discovery. They alsodevelop in-house program of drug discovery and some of them are related to the design of novelglycopeptides-like molecules. Several of these molecules, such as PAR-00387, are toxic for numerous bacteriaincluding Gram-positive animal and human pathogens but the mechanism of action is not known. Theycontacted the lab. of Dr. Veyrier, expert in bacterial cell wall synthesis to answer the specific fundamentalquestions of the mechanism of action of these novel molecules and if they target peptidoglycan. We willtherefore design assays to determine if these molecule can bind and target the synthesis of PG using innovativeand optimized HPLC and electron microscopy protocols. This knowledge will not only help in thecommercialization of this molecule, it will also help in determining the prerequisite for glycopetides to bindPG, and the consequence of inhibiting some steps in PG synthesis on the development of the bacterialcell-cycle.